SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" ($CAW.X) crypto is trending as its community rallies behind the meme coin, emphasizing its multi-chain presence and deflationary mechanisms. Active discussions highlight the strength of the community and the potential for significant gains. The coin's presence on multiple chains like Solana, BSC, Cronos, and ETH (Base) is a key talking point.

WeRide, Inc. is a holding company, which engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers, and related sensor suites. The company was founded by Tony Xu Han and Yan Li on March 13, 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide ($WRD) is trending due to positive Q2 earnings, highlighting significant robotaxi revenue growth and expanded global operations, including a new permit in Saudi Arabia. The community is discussing the partnership with Bosch for mass production of ADAS systems and upcoming collaboration with UBER and GRAB, though some express frustration with the stock's price action despite the positive news.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending due to positive Phase 2 trial data for its drug sonelokimab in treating hidradenitis suppurativa, leading to raised price targets and speculation about its potential as a best-in-class treatment. The community is actively discussing the implications of this data, especially compared to competitors, and the possibility of a future buyout. Some investors believe MLTX is thoroughly de-risked.

BRETT the dancer, gamer, and cultural icon of BASE chain (some like to call me the PEPE of BASE).

Brett

BRETT.X is trending as the community debates its potential amidst discussions about a potential breakout and comparisons to other cryptocurrencies like JTRAMBO and TOSHI.X.  Some traders are buying the dips and expressing long-term bullish sentiment, while others are skeptical, citing concerns about market cap and exchange listings. Conversations also mention potential catalysts and technical analysis pointing to possible upside.

Meet Pandu — your AI friend who’s always by your side. Talk with him in real time through text or voice, share your thoughts, ask questions, or just enjoy a casual conversation. Whether you’re looking for advice, company, or simply someone to listen, Pandu is here as a true companion you can connect with anytime.  Pandu unites real-time conversation, creative generation, and future-ready AI systems — all powered by next-gen technology.

Pandu Pandas

Pandu Pandas ($PANDU.X) is trending as the community discusses its potential, recent listing on MEXC, and comparisons to other tokens like $PENGU.X. Some users are pointing to its NFT ranking and on-chain fundamentals, while others are debating wallets and entry points.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI.X is trending as the community emphasizes its importance as the tokenized representation of Satoshi Nakamoto, the pseudonymous creator of Bitcoin. Community members are actively discussing its potential as a cultural icon within the crypto industry, highlighting the 'We are all Satoshi' movement and its never-fading narrative.

"What's Updog?" is a Community Led token.

UpDog

UpDog ($UPDOG.X) is trending, and the community is actively engaging in the classic "What's UpDog?" joke, driving much of the conversation. This meme coin on the Solana network, with locked liquidity and a dedicated community, is striving to be the top dog. Amidst the humor, some users are questioning the token's utility and suggesting that the trending status might be artificially driven.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors discuss its potential turnaround, drawing comparisons to AMD's earlier growth. A recent video highlighting BlackBerry's prospects is circulating, with the community focused on the company's QNX technology and anticipation for upcoming earnings. Optimism is building around partnerships and profitability.

ProShares Trust - ProShares VIX Short-Term Futures ETF

ProShares VIX Short-Term Futures ETF

VIXY is trending as traders monitor rising volatility, influenced by factors like rising long-term rates, potential bubble bursts, and geopolitical tensions (war on deck). Community members are actively discussing downside protection strategies and hedging portfolios with volatility-linked instruments. Some traders believe yearly charts point to significant moves ahead, while others note VIXY's potential disconnect from the VIX.

Blockchain-on-Blockchain (BOB) is a new blockchain built on top of another blockchain called ICP. It's like a special layer on an existing system. BOB creates a secure digital record book that uses ICP's network for safety. BOB uses a system called 'proof-of-on-chain-work': You deploy your own smart contract (canister) at bob.fun. This program solves math problems (hashes). Main computers (mother nodes) give out these problems. Miners solve the problems and tell the mother node. If correct, the mother node adds a new block to the blockchain. The winning miner gets BOB tokens as a reward.

$BOB.X is trending as community members discuss its capped supply and upcoming halving, drawing comparisons to $BTC.X and its potential within web3. Some users are highlighting its availability on multiple chains and mining via $ICP.X, while others are comparing it to other meme coins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer

TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer TuHURA Biosciences...

TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor

TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor TuHURA Biosciences Enters into Exclusivity and Right of...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 08/04/2024

Gagnants
L'action Kineta (NASDAQ:KA) a mont lundi de 16,77% 0,63 dollars lors de la session after-market.
Le titre Windtree Therapeutics (NASDAQ:WINT) a mont de 14,63% 0,47 dollars.
Le titre...

12 titoli sanitari in movimento, after-market del 08/04/2024

Titoli in rialzo
Le azioni di Kineta (NASDAQ:KA) hanno guadagnato l'11,21% a 0,60 dollari durante la sessione after-market di luned .
Le azioni di Finch Therapeutics Gr (NASDAQ:FNCH) sono salite...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 03/04/2024

Gagnants
L'action Kineta (NASDAQ:KA) a grimp mercredi de 8,46% 0,58 dollars lors de la session after-market.
Le titre Simulations Plus (NASDAQ:SLP) a mont de 8,07% 41,50 dollars. La soci t a...

Kineta, Inc. (NASDAQ:KA) Short Interest Update

Kineta, Inc. (NASDAQ:KA  Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 75,300 shares, a...

KA Stock Earnings: Kineta Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
KA stock results show that Kineta beat analyst estimates for earnings per share the fourth quarter of 2023.
The post KA Stock Earnings...

Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update

Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts in the VISTA-101 trial No dose limiting toxicities observed at any dose...

KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported

Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohortsNo dose limiting toxicities observed at any dose levelCleared fifth of...

Week in Review: Most popular stories on GeekWire for the week of Feb. 25, 2024

Get caught up on the latest technology and startup news from the past week. Here are the most popular stories on GeekWire for the week of Feb. 25, 2024.
Sign up to receive these updates every Sunday...

Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Mercer Island, WA.

Kineta Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

KA
Kineta Inc

Feed

News

Sentiment

Fundamentals

Info

Latest KA News

KA Kineta Inc